Closing the loop with optogenetics

Posted August 27, 2015 | Atlanta, GA - John Toon Optogenetics provides a powerful tool for studying the brain by allowing researchers to activate neurons using simple light-based signals. But until now, these optical stimulation techniques have been “open loop,” meaning they lack the kind of feedback control that most biological and engineering systems use

Neuralstem Updates ALS Stem Cell Trial Progress

Tuesday, May 22, 2012 By: Neuralstem Press Release FDA permits additional dosing of return patients ROCKVILLE, Md., May 8, 2012 /PRNewswire via COMTEX/ -- Neuralstem, Inc. announced that the Federal Drug Administration (FDA) has approved the return of three patients from earlier cohorts in its ongoing Phase I safety trial to treat amyotrophic lateral sclerosis